Susan E Graf - Net Worth and Insider Trading
Susan E Graf Net Worth
The estimated net worth of Susan E Graf is at least $387 dollars as of 2024-04-28. Susan E Graf is the Director of Finch Therapeutics Group Inc and owns about 167 shares of Finch Therapeutics Group Inc (FNCH) stock worth over $387. Details can be seen in Susan E Graf's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Susan E Graf has not made any transactions after 2023-06-09 and currently still holds the listed stock(s).
Transaction Summary of Susan E Graf
Susan E Graf Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Susan E Graf owns 2 companies in total, including Epizyme Inc (EPZM) , and Finch Therapeutics Group Inc (FNCH) .
Click here to see the complete history of Susan E Graf’s form 4 insider trades.
Insider Ownership Summary of Susan E Graf
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EPZM | Epizyme Inc | 2016-04-25 | Chief Business Officer |
| FNCH | Finch Therapeutics Group Inc | 2023-06-09 | director |
Susan E Graf Latest Holdings Summary
Susan E Graf currently owns a total of 1 stock. Susan E Graf owns 167 shares of Finch Therapeutics Group Inc (FNCH) as of June 9, 2023, with a value of $387.
Latest Holdings of Susan E Graf
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FNCH | Finch Therapeutics Group Inc | 2023-06-09 | 167 | 2.32 | 387 |
Holding Weightings of Susan E Graf
Susan E Graf Form 4 Trading Tracker
According to the SEC Form 4 filings, Susan E Graf has made a total of 1 transactions in Finch Therapeutics Group Inc (FNCH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Finch Therapeutics Group Inc is the acquisition of 167 shares on June 9, 2023, which cost Susan E Graf around $1,353.
Insider Trading History of Susan E Graf
- 1
Susan E Graf Trading Performance
GuruFocus tracks the stock performance after each of Susan E Graf's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Susan E Graf is -23.86%. GuruFocus also compares Susan E Graf's trading performance to market benchmark return within the same time period. The performance of stocks bought by Susan E Graf within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Susan E Graf's insider trading performs compared to the benchmark.
Performance of Susan E Graf
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.78 | -23.86 | -52.77 | |||
| Relative Return to S&P 500(%) | 11.45 | -27.55 | -59.88 |
Susan E Graf Ownership Network
Ownership Network List of Susan E Graf
Ownership Network Relation of Susan E Graf
Susan E Graf Owned Company Details
What does Epizyme Inc do?
Who are the key executives at Epizyme Inc?
Susan E Graf is the Chief Business Officer of Epizyme Inc. Other key executives at Epizyme Inc include Chief Scientific Officer Jeffery Kutok , Chief Operating Officer Jerald Korn , and Corporate Controller Joseph Beaulieu .
Epizyme Inc (EPZM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc (EPZM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc (EPZM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Epizyme Inc (EPZM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Epizyme Inc Insider Transactions
Susan E Graf Mailing Address
Above is the net worth, insider trading, and ownership report for Susan E Graf. You might contact Susan E Graf via mailing address: 400 Technology Square, 4th Floor, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
